These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5758247)

  • 1. Therapeutic value of benzalkonium chloride in oral candidosis.
    Gobba AH; Refai M
    Mykosen; 1968 Jul; 11(7):529-30. PubMed ID: 5758247
    [No Abstract]   [Full Text] [Related]  

  • 2. Benzalkonium chloride poisoning in infant twins.
    Wilson JT; Burr IM
    Am J Dis Child; 1975 Oct; 129(10):1208-9. PubMed ID: 1238016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and laboratory observations in the treatment of candidal vulvovaginitis with benzalkonium salts (author's transl)].
    Zhang Z
    Zhonghua Fu Chan Ke Za Zhi; 1979; 14(3):151-4. PubMed ID: 555721
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of topical nasal steroids on human respiratory mucosa and human granulocytes in vitro.
    Steinsvåg SK; Bjerknes R; Berg OH
    Acta Otolaryngol; 1996 Nov; 116(6):868-75. PubMed ID: 8973724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzalkonium chloride: death of an asthmatic patient.
    Prescrire Int; 2008 Aug; 17(96):160. PubMed ID: 19496246
    [No Abstract]   [Full Text] [Related]  

  • 6. [Change in serum concentration of itraconazole according to its dosage form].
    Chineno T
    Jpn J Antibiot; 2008 Apr; 61(2):92-4. PubMed ID: 18709729
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the in vitro spermicide activity and therapeutic use of a benzalkonium chloride base preparation (Agena)].
    Chiara G; Rappelli F
    Minerva Ginecol; 1975 Nov; 27(11):895-9. PubMed ID: 1242527
    [No Abstract]   [Full Text] [Related]  

  • 8. Itraconazole solution: summary of pharmacokinetic features and review of activity in the treatment of fluconazole-resistant oral candidosis in HIV-infected persons.
    Koks CH; Meenhorst PL; Bult A; Beijnen JH
    Pharmacol Res; 2002 Aug; 46(2):195-201. PubMed ID: 12220961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-albicans oral candidosis in HIV-positive patients.
    Cartledge JD; Midgley J; Gazzard BG
    J Antimicrob Chemother; 1999 Mar; 43(3):419-22. PubMed ID: 10223601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular irritation evaluation of benzalkonium chloride in rabbits.
    Britton B; Hervey R; Kasten K; Gregg S; McDonald T
    Ophthalmic Surg; 1976; 7(3):46-55. PubMed ID: 980377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The fungicid effect of clodantoin, benzalkonium chloride and sporostacin].
    Becker H; Schweisfurth R
    Mykosen; 1971 May; 14(5):237-43. PubMed ID: 5103527
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel antimicrobial central venous catheter impregnated with benzalkonium chloride.
    Tebbs SE; Elliott TS
    J Antimicrob Chemother; 1993 Feb; 31(2):261-71. PubMed ID: 8463171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole.
    Ruhnke M; Eigler A; Engelmann E; Geiseler B; Trautmann M
    Infection; 1994; 22(2):132-6. PubMed ID: 8070927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Toxicity of Benzalkonium Chloride.
    Johnson NF
    J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):1-17. PubMed ID: 28683210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural compound magnolol affects growth, biofilm formation, and ultrastructure of oral Candida isolates.
    Behbehani J; Shreaz S; Irshad M; Karched M
    Microb Pathog; 2017 Dec; 113():209-217. PubMed ID: 29074435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
    Ellepola AN; Samaranayake LP
    Dent Update; 2000 May; 27(4):165-70, 172-4. PubMed ID: 11218451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical response to ketoconazole of HIV-related oral candidosis is predicted by Odds' relative growth method of susceptibility testing.
    Cartledge JD; Midgley J; Gazzard BG
    J Antimicrob Chemother; 1997 Jul; 40(1):117-9. PubMed ID: 9249214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral candidosis and the therapeutic use of antifungal agents in dentistry.
    McCullough MJ; Savage NW
    Aust Dent J; 2005 Dec; 50(4 Suppl 2):S36-9. PubMed ID: 16416716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between in vitro toxicity of benzalkonium chloride (BAC) and preservative-induced dry eye.
    De Saint Jean M; Debbasch C; Brignole F; Warnet JM; Baudouin C
    Adv Exp Med Biol; 2002; 506(Pt A):697-702. PubMed ID: 12613979
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative assessment of the efficacy of oral ketoconazole for oral candidosis in HIV-infected patients.
    Korting HC; Blecher P; Fröschl M; Braun-Falco O
    Mycoses; 1992; 35(7-8):173-6. PubMed ID: 1287481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.